vimarsana.com

Page 13 - லண்டன் ஸ்டாக் பரிமாற்றம் பட்டியலிடப்பட்டுள்ளது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Portfolio Company Update: Prometheus IPO

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: Portfolio Company Update: Prometheus IPO
investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: New Investment in Monte Rosa Therapeutics

RTW Participates in $95 Million Financing Round in Monte Rosa Therapeutics RTW Venture Fund Limited (the Company ), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Monte Rosa Therapeutics, Inc. ( Monte Rosa ) on 12 March 2021 of its completion of a $95 million Series C financing round. The Company, alongside other investment vehicles of RTW Investments, LP (the Investment Manager ), confirms that it participated in the financing round together with other investment firms. Monte Rosa is a privately held preclinical-stage biotech company discovering and developing small molecule degraders (also known as molecular glues) to eliminate disease-causing proteins. Monte Rosa plans to use the proceeds from the financing round to advance its lead development candidate into the clinic, accelerate pipeline growth and bolster its pl

Mine that produced Queen s diamond investigates claims of abuses by guards

Investegate |RTW Venture Fund Ltd Announcements | RTW Venture Fund Ltd: New Investment in Tenaya Therapeutics

RTW Leads $106 Million Financing Round in Tenaya Therapeutics RTW Venture Fund Limited (the Company ), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Tenaya Therapeutics, Inc. ( Tenaya ) on 01 March 2021 of its completion of a $106 million Series C financing round led by RTW Investments, LP (the Investment Manager ). The Company, alongside other investment vehicles of the Investment Manager, confirms that it participated in the financing round together with other investment firms. Tenaya is a US-based privately held biotechnology company with a mission to discover, develop, and deliver curative therapies that address the underlying causes of heart disease. Tenaya is developing three platforms to address heart disease: Gene Therapy, Regeneration, and Precision Medicine. The proceeds from the financing round will be used to adv

Kakuzi troubles smoke out reclusive Kenyan billionaire shareholder

THE STANDARD By Wainaina Wambu | February 16th 2021 at 08:02:00 GMT +0300 Dr John Kibunga Kimani Non-Executive Director Kakuzi Plc. Until recently, only a select few could put a face to the name of billionaire investor John Kibunga Kimani. But when human rights abuse allegations rocked Nairobi Securities Exchange-listed Kakuzi, where he is the second-largest shareholder with a 32.2 per cent stake, curiosity about the man behind the name rose. Dr Kimani is also one of the single-largest investors in most blue-chip stocks at the NSE, with his shareholding in these companies alone valued at more than Sh1 billion. Besides Kakuzi, he has shares in East African Breweries, Safaricom, Nation Media Group and Centum. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.